Arich Enterprise Co., Ltd.

4173

TW0004173000

Pharmaceuticals

End-of-day quote Taipei Exchange Other stock markets 23:00:00 30/05/2024 BST			5-day change	1st Jan Change
21.5 ^TWD	+0.23%		+0.23%	-2.05%

05-14	Arich Enterprise Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-20	Arich Enterprise Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Arich Enterprise Co., Ltd. Announces Dividend

March 11, 2022 at 10:40 am

Arich Enterprise Co., Ltd. announced dividend of NTD 0.5 per share.

Latest news about Arich Enterprise Co., Ltd.

Arich Enterprise Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
Arich Enterprise Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-20	CI
Arich Enterprise Co., Ltd. Announces Resignation of Tang Ten-Chien, Representative Director-Lin Feng Co., Ltd	03-12	CI
Arich Enterprise Co., Ltd. Approves Cash Dividend for the Year Ended December 31, 2023, Payable on May 16, 2024	03-08	CI
Arich Enterprise Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09	CI
Arich Enterprise Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23	CI
Arich Enterprise Co., Ltd. Announces Common Share Cash Dividend	26/06/23	CI
Arich Enterprise Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	13/05/23	CI
Arich Enterprise Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	25/03/23	CI
Arich Enterprise Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	25/03/23	CI
Arich Enterprise Co., Ltd. Approves Cash Dividend for the Year Ended December 31, 2022	16/03/23	CI
Arich Enterprise Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	07/11/22	CI
Arich Enterprise Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	08/08/22	CI
Arich Enterprise Co., Ltd. Announces Appointment of Corporate Governance Officer, Effective September 1, 2022	04/08/22	CI
Arich Enterprise Co., Ltd. Announces Cash Dividend, Payable on July 28, 2022	28/06/22	CI
Arich Enterprise Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	09/05/22	CI
Arich Enterprise Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	18/03/22	CI
Arich Enterprise Co., Ltd. Announces Dividend	11/03/22	CI
Arich Enterprise Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	04/11/21	CI
Arich Enterprise Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021	10/08/21	CI
Arich Enterprise Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	12/05/21	CI
Arich Enterprise Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	22/03/21	CI
Arich Enterprise Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020	10/11/20	CI
Arich Enterprise Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020	11/08/20	CI
Arich Enterprise Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020	12/05/20	CI

Chart Arich Enterprise Co., Ltd.

Duration

Period

More charts

Arich Enterprise Co., Ltd. is a Taiwan-based company principally engaged in the sales and marketing of pharmaceuticals, as well as the provision of the related logistics services. The Company is principally engaged in the sale and marketing of prescription drugs for gynaecology, obstetrics, urinary, derma and ophthalmology use; guideline drugs for hair breeding, intestines and stomach and smoking quit, as well as health consumer goods for oral health, daily consuming and beauty care, among others. The Company also provides distribution and logistics services for prescription drugs, guideline drugs, restriction drugs, cold chain drugs, clinical trial drugs and healthcare products, among others. The Company operates its business mainly within domestic market.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
ARICH ENTERPRISE CO., LTD.	-2.05%	49.3M
MCKESSON CORPORATION	+23.03%	74.04B
CARDINAL HEALTH, INC.	-1.52%	24.18B
SINOPHARM GROUP CO. LTD.	+3.67%	8.46B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+8.55%	8.34B
HUADONG MEDICINE CO., LTD	-23.71%	7.64B
H. LUNDBECK A/S	+15.20%	5.33B
GALENICA AG	+2.68%	4.12B
EBOS GROUP LIMITED	-6.90%	3.92B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+5.56%	3.89B